Limited Access Protocol for the Use of Oral Cisapride

Yale University

Status: Completed

Conditions: Gastroparesis

Study type: Observational

Funder types: Other

Identifiers

NCT02524496

0009012025

Details and patient eligibility

About

Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.

Enrollment: 3 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of gastroparesis.

Exclusion criteria

• No diagnosis of gastroparesis.